Artigo Revisado por pares

Neurobiology and Genetics of Pathological Gambling

2002; Slack Incorporated (United States); Volume: 32; Issue: 3 Linguagem: Inglês

10.3928/0048-5713-20020301-07

ISSN

1938-2456

Autores

Ángela Ibáñez, Carlos Blanco, Jerónimo Saiz‐Ruiz,

Tópico(s)

Gambling Behavior and Treatments

Resumo

PATHOLOGICAL GAMBLINGNeurobiology and Genetics of Pathological Gambling Angela Ibáñez, MD, PhD, , , MD, PhD Carlos Blanco, MD, PhD, , and , MD, PhD Jerónimo Sáiz-Ruiz, MD, PhD, , MD, PhD Angela Ibáñez, MD, PhD , Carlos Blanco, MD, PhD , and Jerónimo Sáiz-Ruiz, MD, PhD Psychiatric Annals, 2013;32(3):181–185Published Online:March 01, 2002https://doi.org/10.3928/0048-5713-20020301-07Cited by:13View Full TextPDF ToolsAdd to favoritesDownload CitationsTrack Citations ShareShare onFacebookTwitterLinkedInRedditEmail SectionsMore1. Moreno I, Saiz-Ruiz J, López-Ibor TJ. Serotonin and gambling dependence. Human Psychopharmacology. 1991;6:S9-S12. > Google Scholar2. DeCaria CM, Hollander E, Grossman R, Wong CM, Mosovich SA, Cherkasky S. Diagnosis, neurobiology, and treatment of pathological gambling. / Clin Psychiatry. 1996;57(suppl 8):80-84. > Google Scholar3. Stein DJ, Hollander E, DeCaria CM, Simeon D, Cohen L, Aronowitz B. m-chlorophenylpiperazine challenge in borderline personality disorder: relationship of neuroendocrine response, behavioral response, and clinical measures. Biol Psychiatry. 1996;40:508-513. > Google Scholar4. Oreland L, Ekblom J, Garpenstrand H, Hallman J. Biological markers, with special regard to platelet monoamine oxidase (tnbc-MAO), for personality and personality disorders. Adv Pharmacol. 1998;42:301-304. > Google Scholar5. Blanco Q Oresanz-Muñoz L, Blanco-Jerez C, Sáiz-Ruiz J. Pathological gambling and platelet MAO activity: a psychobiological study. Am J Psychiatry. 1996;153:119-121. > Google Scholar6. Carrasco JL, Sáiz-Ruiz J, Hollander E, Cesar J, Lopez-Ibor JJ Jr. Low platelet monoamine oxidase activity in pathological gambling. Acta Psychiatr Scand. 1994,90:427-431. > Google Scholar7. Roy A, Adinoff B, Roehrich L, et al. Pathological gambling: a psychobiological study. Arch Gen Psychiatry. 1988;45:369-373. > Google Scholar8. Bergh C, Eklund T, Sodersten P, Nordin C. Altered dopamine function in pathological gambling. Psychol Med. 199727:473-475. > Google Scholar9. Nordin C, Eklundh T. Altered CSF 5-H1AA disposition in pathologic male gamblers. CNS Spectrums. 1999;4 Google Scholar10. Hollander E, Frenkel M, DeCaria C, Trungold S, Stein DJ. Treatment of pathological gambling with clomipramine. Am J Psychiatry. 1992;149:710-711. Letter. > Google Scholar11. Hollander E, DeCaria C, Mari E, et al. Short-term single-blind fluvoxamine treatment of pathological gambling. Am J Psychiatry. 1998;155:1781-1783. > Google Scholar12. Hollander E, DeCaria CM, Finkell JN, et al. A randomized double-blind fluvoxamine/ placebo crossover trial in pathological gambling. Biol Psychiatry. 2000;47:813-817. > Google Scholar13. Kim SW, Grant JE, Shin YC, Toth JA, Adson DE, Zaninelli RM. A double-blind, placebo-controlled study of the efficacy and safety of paroxetine in the treatment of pathological gambling disorder. / Clin Psychiatry. In press. > Google Scholar14. Blanco C, Petkova E, Ibáñez A, Sáiz J. A long-term, double-blind, placebo controlled study of fluvoxamine for pathological gambling. Presented at: 152nd Annual Meeting of the American Psychiatric Association; May 1621, 1999; Washington, DC. > Google Scholar15. Roy A, Dejong J, Linnoila M. Extraversion in pathological gamblers. Arch Gen Psychiatry. 1989;46:679-681. > Google Scholar16. Leary K, Dickerson M. Levels of arousal in high and low frequency gamblers. Bchao Res Ther. 1985;23:635-641. > Google Scholar17. Zuckerman M. Psychobiology of Personality. Cambridge: Cambridge University Press; 1991. > Google Scholar18. DeCaria C, Hollander E, Nora R, Stein D, Simeon D, Cohen I. Gambling: biological /genetic, treatment, government, and gambling concerns: neurobiology of pathological gambling. Presented at: 150th Annual Meeting of the American Psychiatric Association; May 1997; San Diego, Calif. > Google Scholar19. Potenza MN, Steinberg MA, Lacadie CM, et al. Neural activations associated with gambling urges in pathological gamblers. Presented at: American College of Neuropsychopharmacology Annual Conference; December 16-21, 2000; San Juan, Puerto Rico. > Google Scholar20. Roy A, Dejong J, Ferraro T, et al. CSF GABA and neuropeptides in pathological gamblers and normal controls. Psychiatry Res. 1989;30:137-144. > Google Scholar21. Blaszczynski AP, Winter SW, McConaghy N. Plasma endorphin levels in pathological gambling. Journal of Gambling Behavior. 1986;2:3-4. > Google Scholar22. Blum K, Sheridan PJ, Wood RC, Braverman ER, Chen TJ, Comings DE. Dopamine D2 receptor gene variants: association and linkage studies in impulsive-addictive-compulsive behaviour. Pharmacogenetics. 1995;5:121-141. > Google Scholar23. Lesieur HR. The female pathological gambler. In: Eadington WR, ed. Gambling Research. Vol. 5. Reno, Nev: Bureau of Business and Economic Research, University of Nevada; 1988. > Google Scholar24. Ibáñez A. Bases Gene'ticas de Ludopatía. Madrid, Spain: Universidad de Alcalá; 1997. Thesis. > Google Scholar25. Eisen SA, Un N, Lyons MJ, et al. Familial influences on gambling behavior: an analysis of 3359 twin pairs. Addiction. 1998;93:1375-1384. > Google Scholar26. SIutske WS, Eisen S, True WR, Lyons MJ, Goldberg J, Tsuang M. Common genetic vulnerability for pathological gambling and alcohol dependence in men. Arch Gen Psychiatry. 2000;57:666-673. > Google Scholar27. Ibáñez A, Perez de Castro I, Fernandez-Piqueras J, Blanco C, Saiz-Ruiz J. Genetic association study between pathological gambling and DNA polymorphic markers at MAO-A and MAO-B genes. MoI Psychiatry. 2000;20:105-109. > Google Scholar28. Ibáñez A, Pérez de Castro I, Fernández-Piqueras J, SáizRuiz J. Association between the low-functional MAO-A gene promoter and pathological gambling. Am J Med Genet. 2000;96:464-465. Abstract. > Google Scholar29. Westlund KN, Krakower TJ, Kwan SW, Abell CW. Intracellular distribution of monoamine oxidase-A Ln selected regions of rat and monkey brain and spinal cord. Brain Res. 1993;612:221-230. > Google Scholar30. Pérez de Castro I, Ibáñez A, Sáiz-Ruiz J, FernándezPiqueras J. Genetic contribution to pathological gambling: association between a functional DNA polymorphism at the serotonin transporter gene (5-HTT) and affected males. Pharmacogenetics. 1999;9:397-400. > Google Scholar31. Comings DE, Rosenthal RJ, Lesieur HR, et al. A study of the dopamine D2 receptor gene in pathological gambling. Pharmacogenetics. 1996;6:223-234. > Google Scholar32. Perez de Castro I, Ibáñez A, Torres P, Saiz-Ruiz J, Fernandez-Piqueras J. Genetic association study between pathological gambling and a functional DNA polymorphism at the D4 receptor. Pharmacogenetics. 1997;7:345-348. > Google Scholar33. Ibáñez A, Pérez de Castro 1, Fernández-Piqueras ], SáizRuiz J. Sex differences in pathological gambling genetic contribution. Am J Med Genet. 1998;81:523. Abstract. > Google Scholar Previous article Next article FiguresReferencesRelatedDetailsCited by Murase H (2018) Casino legalization and gambling disorder: A comprehensive review and recommendations, Journal of Health Psychology Research, 10.11560/jhpr.170601075, 30:Special_issue, (217-227), Online publication date: 1-Feb-2018. Morris L and Voon V (2016) Dimensionality of Cognitions in Behavioral Addiction, Current Behavioral Neuroscience Reports, 10.1007/s40473-016-0068-3, 3:1, (49-57), Online publication date: 1-Mar-2016. Grant J and Odlaug B (2014) Diagnosis and Treatment of Gambling Disorder Behavioral Addictions, 10.1016/B978-0-12-407724-9.00003-3, (35-59), . Grant J, Odlaug B and Donahue C (2013) Gambling The Wiley Handbook of Cognitive Behavioral Therapy, 10.1002/9781118528563.wbcbt57, (1359-1388), Online publication date: 10-Oct-2013. Ferentzy P and Turner N (2013) Current Situation and Future Directions The History of Problem Gambling, 10.1007/978-1-4614-6699-4_7, (121-149), . Dussault F, Brendgen M, Vitaro F, Wanner B and Tremblay R (2010) Longitudinal links between impulsivity, gambling problems and depressive symptoms: a transactional model from adolescence to early adulthood, Journal of Child Psychology and Psychiatry, 10.1111/j.1469-7610.2010.02313.x, 52:2, (130-138), Online publication date: 1-Feb-2011. Hammelstein P and Roth M (2010) Testing the validity of the Need Inventory (NISS) within a clinical context: The role of pathological gambling, Journal of Research in Personality, 10.1016/j.jrp.2010.07.003, 44:5, (661-664), Online publication date: 1-Oct-2010. Grant J and Odlaug B (2010) Pathological Gambling: Clinical Aspects Impulse Control Disorders, 10.1017/CBO9780511711930.006, (51-74) Shah K, Potenza M and Eisen S (2010) Basi biologiche del gioco d'azzardo patologico Il gioco d'azzardo patologico, 10.1007/978-88-470-1538-8_9, (117-132), . Drapier D, Drapier S, Sauleau P, Derkinderen P, Damier P, Allain H, Vérin M and Millet B (2006) Pathological gambling secondary to dopaminergic therapy in Parkinson's disease, Psychiatry Research, 10.1016/j.psychres.2006.04.017, 144:2-3, (241-244), Online publication date: 1-Nov-2006. Shah K, Eisen S, Xian H and Potenza M (2005) Genetic Studies of Pathological Gambling: A Review of Methodology and Analyses of Data from the Vietnam Era Twin Registry, Journal of Gambling Studies, 10.1007/s10899-005-3031-x, 21:2, (179-203), Online publication date: 1-Jun-2005. Hammelstein P (2004) Faites vos jeux! Another look at sensation seeking and pathological gambling, Personality and Individual Differences, 10.1016/j.paid.2003.10.014, 37:5, (917-931), Online publication date: 1-Oct-2004. Daughters S, Lejuez C, Lesieur H, Strong D and Zvolensky M (2003) Towards a better understanding of gambling treatment failure: implications of translational research, Clinical Psychology Review, 10.1016/S0272-7358(03)00037-0, 23:4, (573-586), Online publication date: 1-Jul-2003. Request Permissions InformationCopyright 2013, SLACK IncorporatedPDF download • 8.7 MB Published online3/01/02

Referência(s)
Altmetric
PlumX